Kurt P. Rindoks - 26 Aug 2022 Form 4 Insider Report for KEWAUNEE SCIENTIFIC CORP /DE/ (KEQU)

Role: VP - Global Prod Development
Signature: /s/ Donald T. Gardner III, Attorney-in-fact
Issuer symbol: KEQU
Transactions as of: 26 Aug 2022
Net transactions value: +$17.2
Form type: 4
Filing time: 29 Aug 2022, 14:35:26 UTC
Previous filing: 09 Jul 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	KEQU	Common Stock	Options Exercise	$50,910	+3,000	+21%	$16.97	17,546	26 Aug 2022	Direct	F1
transaction	KEQU	Common Stock	Tax liability	$50,893	-2,560	-15%	$19.88	14,986	26 Aug 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	KEQU	Option to Buy FY16	Options Exercise	$0	-3,000	-100%	$0.000000^*	0	26 Aug 2022	Common Stock	3,000	$16.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consideration for the exercise of the underlying option to buy was paid through a "net exercise" by directing the company to retain as payment for the total exercise cost a sufficient number of shares of Common Stock that would have been otherwise received upon exercise as reported below on this Form 4 report.
F2	Employee stock option granted under Employee Stock Option plan under Rule 16b-3.